BCAN Announces $1 Million Grant to Propel Bladder Cancer Research Forward
On July 8, 2025, the Bladder Cancer Advocacy Network (BCAN) introduced its latest initiative, a Funding Continuity Grant of up to $1 million aimed at sustaining critical bladder cancer research. This program targets research projects that have faced disruptions due to fluctuations in federal funding, ensuring that vital research can continue without interruption.
BCAN has a storied history, having provided over $11 million in grants to stimulate innovative research in the field. BCAN's CEO, Meri-Margaret Deoudes, emphasized the importance of maintaining momentum in cancer research, stating, “We have seen incredible momentum in bladder cancer research and it's important to continue to make progress.” She further highlighted the ongoing discoveries that are pivotal in facilitating earlier detection, developing more effective treatments, and ultimately, extending patient lifespans. The continuous support these grants offer is essential for keeping this upward trajectory.
In light of the uncertainty surrounding federal financing, BCAN's Funding Continuity Grant serves as a crucial mechanism to bridge gaps and ensure that essential research projects do not stall. Deoudes reiterated BCAN's commitment, noting, “For 20 years, BCAN has been dedicated to creating better todays and more tomorrows for bladder cancer patients and families. This continuity grant builds on that longstanding commitment.” The urgency of this initiative is underscored by the staggering statistics that suggest over 84,000 individuals will receive a bladder cancer diagnosis this year, with certain demographics such as veterans being disproportionately affected.
The grant is available to researchers associated with academic and medical institutions in the United States. Interested investigators can find more information on how to apply for the Funding Continuity Grant by visiting BCAN's official website. The Bladder Cancer Advocacy Network was founded in 2005 and plays a crucial role in empowering patients with essential information and community support while also driving innovative research and influencing national policies aimed at improving the lives of those affected by bladder cancer.
With this new program, BCAN not only ensures the survival of critical research initiatives but also fosters an environment where breakthroughs in bladder cancer treatment become increasingly possible. The announcement of this grant shines a light on the ongoing needs within the field and reflects BCAN's unwavering dedication to the bladder cancer community.
BCAN has a storied history, having provided over $11 million in grants to stimulate innovative research in the field. BCAN's CEO, Meri-Margaret Deoudes, emphasized the importance of maintaining momentum in cancer research, stating, “We have seen incredible momentum in bladder cancer research and it's important to continue to make progress.” She further highlighted the ongoing discoveries that are pivotal in facilitating earlier detection, developing more effective treatments, and ultimately, extending patient lifespans. The continuous support these grants offer is essential for keeping this upward trajectory.
In light of the uncertainty surrounding federal financing, BCAN's Funding Continuity Grant serves as a crucial mechanism to bridge gaps and ensure that essential research projects do not stall. Deoudes reiterated BCAN's commitment, noting, “For 20 years, BCAN has been dedicated to creating better todays and more tomorrows for bladder cancer patients and families. This continuity grant builds on that longstanding commitment.” The urgency of this initiative is underscored by the staggering statistics that suggest over 84,000 individuals will receive a bladder cancer diagnosis this year, with certain demographics such as veterans being disproportionately affected.
The grant is available to researchers associated with academic and medical institutions in the United States. Interested investigators can find more information on how to apply for the Funding Continuity Grant by visiting BCAN's official website. The Bladder Cancer Advocacy Network was founded in 2005 and plays a crucial role in empowering patients with essential information and community support while also driving innovative research and influencing national policies aimed at improving the lives of those affected by bladder cancer.
With this new program, BCAN not only ensures the survival of critical research initiatives but also fosters an environment where breakthroughs in bladder cancer treatment become increasingly possible. The announcement of this grant shines a light on the ongoing needs within the field and reflects BCAN's unwavering dedication to the bladder cancer community.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.